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ARTICLE
ArfB can displace mRNA to rescue stalled
ribosomes
Christine E. Carbone1, Gabriel Demo 1,2, Rohini Madireddy1,3, Egor Svidritskiy1,4✉ & Andrei A. Korostelev 1✉
Ribosomes stalled during translation must be rescued to replenish the pool of translation-
competent ribosomal subunits. Bacterial alternative rescue factor B (ArfB) releases nascent
peptides from ribosomes stalled on mRNAs truncated at the A site, allowing ribosome
recycling. Prior structural work revealed that ArfB recognizes such ribosomes by inserting its
C-terminal α-helix into the vacant mRNA tunnel. In this work, we report that ArfB can
efficiently recognize a wider range of mRNA substrates, including longer mRNAs that extend
beyond the A-site codon. Single-particle cryo-EM unveils that ArfB employs two modes of
function depending on the mRNA length. ArfB acts as a monomer to accommodate a shorter
mRNA in the ribosomal A site. By contrast, longer mRNAs are displaced from the mRNA
tunnel by more than 20 Å and are stabilized in the intersubunit space by dimeric ArfB.
Uncovering distinct modes of ArfB function resolves conflicting biochemical and structural
studies, and may lead to re-examination of other ribosome rescue pathways, whose functions
depend on mRNA lengths.
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A translating ribosome is normally recycled after the releaseof the nascent protein at the end of the mRNA openreading frame. Bifunctional proteins called release factors
(RF1 and RF2 in bacteria) recognize stop codons and hydrolyze
peptidyl-tRNA, discharging the peptide from the ribosome. The
hydrolysis is catalyzed by the universally conserved GGQ motif of
RFs in the peptidyl transferase center (PTC) of the ribosome
(reviewed in refs. 1–5). However, ribosomes may stall on an
mRNA due to rare codons, mRNA structure, or the absence of a
stop codon caused by truncation or mutation6,7, giving rise to
2–4% of stalled ribosomes in E. coli8. Without a stop codon,
various rescue strategies are used to release the peptides from
stalled ribosomes7,9. Bacterial alternative rescue factor B (ArfB;
formerly YaeJ) is a small ~140-aa peptidyl-tRNA hydrolase that
lacks a stop-codon recognition domain. The GGQ-containing N
domain is structurally similar to those of release factors, while the
C-terminal tail is disordered in solution10. Eukaryotes encode a
homologous protein ICT1 (“immature colon carcinoma tran-
script-1”, also termed MRPL58), essential in human cells11,12.
ICT1 serves as a mitochondrial ribosome rescue factor12,13 and
large-subunit mitochondrial ribosomal protein14. Crystal struc-
ture of a 70S•ArfB ribosome complex with an mRNA truncated at
the P site codon (i.e., no overhang in the A site) revealed ArfB in
the A site15. The C terminus is folded into an α-helix in the
mRNA tunnel, whereas the catalytic N-terminal domain is
inserted into the PTC. Positively-charged C-terminal residues are
stabilized by interactions with the 16S ribosomal RNA nucleo-
tides forming the mRNA tunnel, rendering the C-terminal tail the
sensor of ribosomes with a vacant tunnel. While this position of
ArfB is incompatible with a longer mRNA extending into the
tunnel15, biochemical data demonstrated that ArfB can also act
on ribosomes stalled on a 21-nucleotide rare-codon cluster, which
extends beyond the A site16. The homologous ICT1 was also
reported to act on ribosomes with long mRNAs17. It therefore
remains unclear how ArfB recognizes stalled ribosomes with
varying mRNA lengths and/or sequences.
In this work, we report biochemical and structural results
revealing two modes of ArfB action. Biochemical data demon-
strate that ArfB efficiently functions on mRNAs with a short
overhang extending into the A site (+1 to +3 nucleotides beyond
the P-site codon) and, surprisingly, on mRNAs that could fill the
mRNA tunnel (+9 nucleotides beyond the P-site codon). The
efficiency of ArfB is decreased on substantially longer mRNAs
that are likely to extend beyond the mRNA tunnel (+21
nucleotides beyond the P site). We used cryogenic electron
microscopy (cryo-EM) to visualize how ArfB acts on distinct 70S
substrates. Extensive classification of two cryo-EM data sets
resolves ensembles of 70S•ArfB structures with shorter and longer
mRNAs. ArfB functions strictly as a monomer on a shorter +2
mRNA, whose overhang is stabilized by decoding center
nucleotides A1492 and A1493. By contrast, dimeric ArfB stabi-
lizes the longer +9 mRNA outside the mRNA tunnel. These
findings allow to reconstruct two pathways for ArfB-mediated
rescue of stalled ribosomes.
Results and discussion
ArfB functions on mRNAs extending into and beyond the A
site. To measure ArfB function, we performed [35S]-N-formyl-
methionine release experiments (see “Methods” and ref. 18) on E.
coli 70S ribosomes programmed with mRNAs of varying lengths
and sequences. We used three groups of mRNAs extending
beyond the P-site AUG codon: (1) containing a short overhang of
three or fewer nucleotides extending into the A site, (2) filling the
mRNA tunnel with an overhang of +9 nucleotides, or (3)
extending beyond the ~12-nucleotide mRNA tunnel with an
overhang of +21 nucleotides19–21. The longer mRNAs contained
a poly-arginine/leucine stalling site (AGG/CUG16), poly-lysine-
encoding sequence (AAA codons), or a poly-pyrimidine sequence
(Fig. 1a, Supplementary Table 1). Surprisingly, ArfB efficiently
catalyzed release from ribosomes programmed with short and +9
mRNAs, whose sequences modestly affected release rates
(Fig. 1c). The low nanomolar KM for both short and +9 mRNAs
(20 nM or lower; Supplementary Fig. 1) suggest efficient binding
of ArfB to these substrates, likely commensurate with cellular
concentrations of ArfB homologs12,13. ArfB had a reduced but
detectable activity on a+21 mRNA with a poly-arginine stalling
sequence (AGG)4 previously reported to be a substrate for ArfB
(Fig. 1b, c16).
Cryo-EM reveals three conformations of ArfB on the+ 2
mRNA. To understand the structural basis for ArfB function on
mRNAs of different lengths, we determined cryo-EM structures
of 70S ribosomal complexes programmed with mRNAs con-
taining a+2 (Fig. 2) or +9 (Fig. 3) poly-adenosine overhang.
Maximum-likelihood classification revealed several structures in
each dataset, featuring ribosomes in different conformations.
Previous studies found that the ribosome adopts non-rotated and
rotated conformations during canonical RF-catalyzed peptide
release22,23. The non-rotated (classical) conformation is the pri-
mary substrate for RF binding24. It contains P-site tRNA, whose
anticodon stem loop is bound to the mRNA codon on the small
30S subunit and the CCA end is in the P site of the large 50S
subunit25,26. An ~10° rotation of the 30S subunit relative to the
large subunit shifts the tRNA’s CCA end into the E site of the 50S
subunit, so the tRNA adopts a hybrid P/E state. Intersubunit
rotation prepares the ribosome for release-factor dissociation27,28
and recycling29–31.
The +2 dataset yielded five cryo-EM maps that suggest how
ArfB functions on a short-mRNA substrate (Fig. 2, Supplemen-
tary Fig. 2, Supplementary Table 2). A 3.8-Å structure (+2-I)
reports a non-rotated ribosome with the P-site tRNA and a
vacant A site (Fig. 2a), resembling a pre-release or post-release
state without a release factor28. Two 3.7 Å maps (+2-II and +2-
IV) and a 3.8 Å map (+2-III) report non-rotated ribosomes with
ArfB in different conformations (Fig. 2b–d). A 3.5-Å rotated 70S
structure (+2-V) does not contain ArfB (Fig. 2e).
Structures +2-II through +2-IV bring insights into the
dynamics of ArfB in the ribosomal A site (Figs. 2b–d and 2g–i).
In Structure +2-II, the catalytic domain is in the PTC and C-
terminal α-helix is in the mRNA tunnel, resembling ArfB in a
complex with no mRNA overhang15. The catalytic26 GGQ28
motif is placed next to the terminal A76 of the P-site tRNA,
consistent with catalytically engaged ArfB (Fig. 2g). The linker
connecting the catalytic domain with the C-terminal helix (aa
101-112) contacts the tip of helix 69 (H69) of 23S rRNA at
nucleotides A1913 and C1914 (Fig. 2g, h). In Structures +2-III
and +2-IV, however, the catalytic domain is retracted from the
PTC (Fig. 2h, i) and the GGQ loop is not resolved. The N-
terminal domains are either partially (+2-III) or fully (+2-IV)
collapsed onto H69, while the C-terminal α-helix remains in the
mRNA entry tunnel. In the fully collapsed conformation, the N
domain is shifted ~12 Å toward the 30S subunit A-site and
rotated (Fig. 2i), placing a patch of positively charged residues
(Arg6, His7, and Arg55) next to the phosphate backbone of H69
at C1914 and U1915 (Fig. 2h, i).
Ribosomal decoding center stabilizes +2 mRNA. The +2
mRNA structures reveal that decoding center nucleotides rear-
range to resolve the anticipated steric clash between the mRNA
overhang and ArfB15. Here, A1492 and A1493 of 16S rRNA are
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within helix 44 and stack with the +2 nucleotide of the mRNA
(Fig. 2f). The interaction shifts the overhang and widens the entry
to the mRNA tunnel. This conformation of DC contrasts that in
the crystal structure with no mRNA overhang, where A1493 is
rotated by ~90° to bulge out of helix 44 and pack on Pro110 of the
ArfB linker (Fig. 3l15). The differences reveal the plasticity of the
decoding center, allowing ArfB to rescue stalled ribosomes that
carry different mRNA overhangs.
The catalytically engaged Structure +2-II and previously
unseen disengaged conformations of ArfB (+2-III and +2-IV)
are consistent with a proposed mechanism for ArfB activation on
stalled ribosomes15. The C-terminal helix acts as a sensor that
binds a ribosome with a vacant mRNA tunnel or with a
rearranged decoding center that accommodates a short mRNA
overhang. Once the C terminus is anchored, the flexible ArfB
linker allows the catalytic N domain to sample intersubunit space
and insert into the PTC, releasing the peptide. This mechanism
ensures recognition of the stalled ribosome before the catalytic
domain is poised to act, preventing ArfB from spontaneously
releasing peptides in actively translating ribosomes.
Dimeric ArfB binds long +9 mRNA outside the mRNA tunnel.
Cryo-EM analysis of the 70S complex formed with +9 mRNA
yielded six ~3.5 Å structures (Supplementary Fig. 3; Supplemen-
tary Table 3), which reveal unexpected differences from the
+2 complex. The mRNA tunnel of non-rotated 70S is occupied
by the ArfB C-terminal helix, while the N domain is not resolved
(+9-I; Fig. 3a), present as a monomer (+9-II; Fig. 3b) or present
as a dimer (+9-III; Fig. 3c). The mRNA overhang is outside the
mRNA tunnel and is stabilized by ArfB found predominantly in
the dimeric state (+9-III; Fig. 3c). Unlike the +2 complex, rotated
ribosome conformations are sampled either with ArfB (+9-IV
and +9-V; Fig. 3d, e) or without ArfB (+9-VI; Fig. 3f).
Ribosome particle distribution reveals that non-rotated ribo-
somes with dimeric ArfB are two times more abundant than those
with monomeric ArfB (Supplementary Figs. 4–5; Supplementary
Tables 2-4). In Structure +9-III, the catalytic monomer (ArfB-1)
is nearly identical to that formed on the short mRNAs or in
Structure +9-II with monomeric ArfB (Figs. 2b, c; 3b, c). The
second ArfB molecule in the intersubunit space (ArfB-2) is
sandwiched between ArfB-1, P-site tRNA, H69 and mRNA
(Fig. 3g–k). Cryo-EM density allows unambiguous assignment of
secondary structure for ArfB-2 in Structure +9-III (Fig. 3k). Data
classification revealed 8 additional classes with less-resolved ArfB-
2 density, indicating that dynamic ArfB-2 samples different
contacts with its interaction partners (Supplementary Fig. 6). In
Structure +9-III, N-terminal residues of ArfB monomers interact
forming a two-strand β-sheet (Fig. 3j; Supplementary Fig. 3e).
ArfB-2 is further stabilized by interactions of a short helix (at
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Fig. 1 Catalytic activity of ArfB on 70S ribosomes with mRNAs of different lengths and sequences. a Schematic of ribosome complexes programmed
with mRNAs that extend 0-21 nucleotides beyond the P site (AUG codon). b Time courses of ArfB-catalyzed [35S]-fMet release from 70S complexes with
mRNAs with or without poly-adenosine overhangs. CPM readout was normalized relative to the signal for the mRNA with no overhang (AUG) at 1 h (N= 3
independent experiments). c Apparent rates (v0) of ArfB-catalyzed fMet release from ribosomes with mRNAs containing poly-pyrimidine (denoted Y),
poly-A, and poly-arginine/leucine-encoding sequences (codons listed) of different lengths (N.D. not detected). (Error bars represent errors of fit from
N= 3 independent experiments).
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P-site tRNA (at C66 and C67) (Fig. 3h). The long helix of the N-
terminal domain is docked between the tip of H69 (Fig. 3i) and
the linker of ArfB-1 (at Lys103; Fig. 3j). The GGQ loop and the
C-terminal tail are not resolved, consistent with structural
flexibility of these regions in catalytically disengaged ArfB-2.
ArfB-2 is flipped nearly 180 degrees relative to ArfB-1, so its C
terminal region faces the 50S subunit, making ArfB-2 incompa-
tible with binding the mRNA tunnel (Supplementary Fig. 3f).
ArfB-2 exposes a patch of positively-charged and hydrophobic
residues (His62-Leu63, Lys73 and Arg90) to stabilize the bases of
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Fig. 2 Cryo-EM structures of the 70S complex formed with +2 mRNA and ArfB. a–e Overall views of five cryo-EM structures with and without ArfB.
f Cryo-EM density (mesh) showing the mRNA +2 overhang stabilized by decoding center nucleotides in Structures +2-I through +2-V (Structure+ 2-II is
shown; map was sharpened by a B-factor of −50 Å2). g–i Close-up view of structures +2-II, +2-III, and +2-IV with ArfB in the fully extended (g), partially
collapsed (h) and fully collapsed (i) conformations, respectively. The arrow in panel i indicates rotation of N domain relative to that in panel h.
j Rearrangement of 23S rRNA helix 69 (H69) in the rotated 70S ribosome without ArfB (+2-V) relative to H69 in Structure +2-IV (gray).
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Fig. 3 Cryo-EM structures of the 70S complex formed with +9 mRNA and ArfB. a–f Overall views of six cryo-EM structures with and without ArfB.
g Cryo-EM density (mesh) showing mRNA (blue) outside the mRNA and interactions with P-site tRNA (orange), ArfB-1 (red), and ArfB-2 (green) (B=
−25 Å2 except for ArfB-2 which was softened by B= 100 Å2). h–j Close-up views showing ArfB-2 interactions with P-tRNA, helix 69, ArfB-1 and mRNA.
Two-strand β-sheet formed by ArfB-1 and ArfB-2 N-termini is in purple (j). k Cryo-EM density for ArfB-2 (B= 50 Å2). l Different conformations of the
decoding center nucleotide 1493 in 70S•ArfB complexes formed on the +2 mRNA (gray) and +9 mRNA (yellow). Structure +9-III is shown in panels g–l.
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the mRNA overhang (positions +3 to +6). The mRNA is
retracted from its canonical position in the mRNA tunnel by
more than 20 Å (Fig. 3g, j; (measured at residue +432)). To
accommodate at the tightly packed A site, the mRNA takes a
sharp turn immediately after the P-site codon, placing +1 and +2
nucleotides next to the anticodon stem loop of the P-site tRNA
(Fig. 3g). The backbone of the mRNA overhang (+4 to +6) is
placed next to the hydrophilic residues of ArfB-1 linker at
Arg109, Thr111, and Arg112 (Fig. 3g and Supplementary 7a),
suggesting that the catalytic monomer also contributes to mRNA
stabilization outside the tunnel. Indeed, mRNA adopts a similar
conformation in the less abundant Structure +9-II with
monomeric ArfB (Fig. 3b). Conformation of the decoding center
in the +9 structures differs from that formed on the +2 mRNA
and resembles that in the crystal structure with no mRNA
overhang15 (Figs. 2f; 3l).
Comparison of the +2 and +9 data sets reveals that ArfB
dimerization is specific for the ribosomes with longer mRNA.
First, extensive classification of the +2 complex data set, using the
same algorithms as for the +9 data set, yielded exclusively
monomeric and ArfB-vacant ribosomes, demonstrating that
dimeric ArfB is beyond the detection limit in the 70S complex
with a short mRNA overhang (Supplementary Fig. 4). Second,
non-rotated ribosomes with ArfB dimer are substantially more
abundant than vacant or monomeric-ArfB-bound 70S (Supple-
mentary Fig. 4, Supplementary Fig. 5), suggesting that longer
mRNA increases the affinity of ArfB dimer to the ribosome.
Indeed, NMR studies report monomeric ArfB in solution,
indicating that the requirements for dimerization are not met
for isolated ArfB10. Position of mRNA outside the tunnel suggests
that ArfB binding correlates with large-scale dynamics of mRNA.
The mRNA tunnel is formed between the head and body of the
30S subunit, which rearrange during translation elongation33.
Rotation of the head relative to the body (also known as “head
swivel”) can achieve ~20°. The opening between these 30S
domains allows mRNA to sample conformations outside the
mRNA tunnel34,35. ArfB dimerization likely shifts the mRNA
dynamic equilibrium by fixing longer mRNAs outside the mRNA
tunnel. This stabilization would allow ArfB-1 to achieve a
catalytically active conformation and release the nascent peptide
from P-site tRNA.
ArfB and 70S intersubunit rotation. +2 and +9 complexes
differ in the occupancies of ArfB on the rotated 70S ribosome,
suggesting that ArfB dissociation during intersubunit rotation
occurs differently. Similarly to the post-termination 70S com-
plexes with RF228, the A site of the rotated Structure +2-V (~7°)
is vacant (Fig. 2e and Supplementary Fig. 2). The head of the
small subunit is modestly swiveled (~5°). The central intersubunit
bridge is disassembled, as H69 is disengaged from its canonical
position in the 30S decoding center and is packed onto the 50S
subunit (Fig. 2j). In this position, H69 would clash with ArfB
(Supplementary Fig. 3d), consistent with dissociation of ArfB
upon intersubunit rotation.
By contrast, ribosomes programmed with the longer +9
mRNA sample partially (4°) and fully (9°) rotated 70S
conformations, which feature ArfB in the A site (Fig. 3d, e) or
a vacant A site (Fig. 3f). Classification revealed ten maps
(Supplementary Fig. 3 and Supplementary Table 3), three of
which were modeled as representative states (Fig. 3d–f). The
partially rotated conformations (Fig. 3d) have the 30S head
swiveled by ~14° toward the 50S subunit, resembling mid-rotated
ribosome in EF-G-bound translocation complexes36. In both
partially and fully rotated ribosomes with ArfB, the positions and
occupancies of the catalytic ArfB and ArfB-2 vary
(Supplementary Table 3, Supplementary Figs. 5, 6). In nine maps
with ArfB, the C-terminal helix is less resolved in the mRNA
tunnel than in the non-rotated ribosome (e.g., Structure +9-IV;
Fig. 3d, e; Supplementary Fig. 7), suggesting destabilization of the
helix upon intersubunit rotation and head swivel. The mRNA
overhang is unresolved in all but one map, in which mRNA is
bound to dimeric ArfB (Supplementary Table 3). Rotated 70S
without ArfB contains mRNA in the tunnel (Structure+ 9-VI;
Fig. 3f and Supplementary 7c), consistent with mRNA re-entering
the tunnel upon ArfB dissociation. Similar to the +2 mRNA, the
ArfB-vacant rotated 70S ribosome features H69 detached from
the decoding center and pointing toward the A site. In this
position, H69 would sterically clash with ArfB (Fig. 3f and
Supplementary Fig. 3d).
Ribosome particle distribution in the +9 data set reveals that
the occupancy of ArfB dimer decreases upon intersubunit
rotation (Supplementary Table 4; Supplementary Fig. 5). The
occupancy of monomeric ArfB, however is higher on partially
and fully rotated ribosomes (Supplementary Fig. 4), suggesting
that the ArfB dimer may dissociate step-wise via monomeric
states. Dissociation of the catalytic ArfB is likely inefficient
because it is stabilized by the displaced mRNA and/or by A1493
(Fig. 3l). Nevertheless, the appearance of rotated ribosomes
without ArfB (+9-IV; Fig. 3f and Supplementary Fig. 3) is
consistent with ArfB dissociation upon intersubunit rotation.
Thus, in both +2 and +9 datasets, intersubunit rotation is
correlated with ArfB dissociation, similarly to canonical termina-
tion complexes with RF1 and RF227,28. Stalled ribosomes with
longer mRNAs appear to represent a challenging substrate for
dimeric ArfB dissociation after peptide release. GTPase release
factor RF3, which stabilizes the rotated conformation27,29,30,
could assist ArfB dissociation in the cell, echoing the role of RF3
in RF1 dissociation from post-termination ribosomes22,27.
ArfB mechanism: two modes of ribosome rescue. Our findings
reveal that ArfB has two modes of function depending on the
length of mRNA in a stalled ribosome, and suggest the structural
mechanisms for ArfB-mediated ribosome rescue (Fig. 4). Upon
stalling on a truncated mRNA or a rare-codon cluster, the ribo-
some adopts a non-rotated conformation with peptidyl-tRNA in
the P site. Truncation of mRNA in the A site (as in the 0 or +2
complexes) or a rare codon prevent efficient mRNA decoding by
aminoacyl-tRNA, leaving the vacant A site accessible to ArfB.
Short mRNA overhangs can be stabilized by the decoding center
nucleotides, permitting entry of the C-terminal tail of ArfB into
the mRNA tunnel (Fig. 4a). Anchoring the C-terminal helix in the
tunnel exposes the N-terminal domain, connected via a flexible
linker, to explore the intersubunit space in the vicinity of the A
site. Mutational studies demonstrate that the linker length and C-
terminal residues are critical for ArfB binding and catalysis10,16,
suggesting that C-terminal binding precedes the insertion of the
catalytic domain into the PTC. Our structures +2-III and +2-IV
raise a possibility that transient interactions of the N-terminal
domain with H69 outside the PTC might precede or coincide
with C-terminus binding in the tunnel. However, the early steps
and mechanism by which the flexible C-terminus recognizes the
mRNA tunnel remain to be elucidated. Subsequent insertion of
the N-terminal domain into the peptidyl transferase center
positions the universally conserved catalytic GGQ motif next to
the scissile ester bond of peptidyl-tRNA, similarly to those in RF-
bound structures (reviewed in refs. 1–5). Deacylation of P-site
tRNA allows the ribosome to spontaneously sample intersubunit
rotation37, bringing the deacylated tRNA into the E site of the
large subunit38. Our structures demonstrate that ArfB occupancy
decreases upon intersubunit rotation (Supplementary Fig. 4 and
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Supplementary Fig. 5), consistent with ArfB dissociation. Struc-
tures +2-II through +2-IV are consistent with step-wise dis-
sociation of ArfB from the ribosome, with the N-terminal domain
dissociating before the C-terminal tail. Movement of H69 and
rearrangement of ribosomal subunits, including head rotation,
likely destabilize ArfB leading to its dissociation (Supplementary
Fig. 3d). The rotated 70S is a substrate for recycling factor RRF39,
which splits the ribosomes into the subunits, preparing them for
translation of other mRNAs.
The evolution of structural states on ribosomes with longer-
mRNA substrates is different, as expected from steric incompat-
ibility of mRNA and ArfB in the mRNA tunnel (Fig. 4b, c). Here,
downstream mRNA is stabilized outside the tunnel by an
additional copy of ArfB, allowing the catalytic ArfB to perform
its function. Thus, ArfB is an unusual enzyme that efficiently
recognizes two groups of substrates via distinct multimerization
states. Observation of mRNA dynamics and positions outside the
mRNA tunnel, however, is not unprecedented. The majority of
cryo-EM and crystal structures of ribosomes report a poorly
ordered A-site codon in the absence of A-site tRNA or protein
factors, and do not resolve mRNA in the entry tunnel. This
indicates that mRNA downstream the P-site codon is conforma-
tionally unstable in the absence of a stabilizing A-site interaction.
Furthermore, downstream mRNA with high propensity for
secondary-structure formation can depart from the mRNA
tunnel and fold in the A site34,40. It is possible therefore, that
in addition to the truncated and rare-codon substrates, ArfB also
recognizes no-go complexes with structured mRNA downstream
the tunnel. By contrast, the catalytic activity of ArfB is low if
mRNA is efficiently decoded by aminoacyl-tRNAs and is
stabilized in the mRNA tunnel (Fig. 1b, c), preventing codon-
independent peptide release on actively translating ribosomes.
Dimerization-dependent rescue may underlie an expanded
repertoire of ArfB targets upon upregulation of ArfB under stress
or other conditions. Nevertheless, our findings do not rule out
that ArfB could function as a monomer on some stalled
ribosomes in a mRNA-sequence-dependent manner (Fig. 4b),
as suggested by the study published while our manuscript was
under review41.
Our findings shed light on a broader range of rescue
mechanisms, reconciling the conflicting structural and biochem-




































































Fig. 4 Proposed mechanism of ArfB-mediated rescue of ribosomes stalled on short and longer mRNAs. a Schematic of ArfB-mediated rescue of
ribosomes stalled on mRNAs extending by a few nucleotides beyond the P site. b Schematic of ArfB-mediated rescue of ribosomes stalled on longer
mRNAs extending into the mRNA tunnel. c Close-up views of cryo-EM structures+9-I, +9-III,+9-IV, and+9-VI showing rearrangements of P-tRNA, ArfB,
mRNA, and H69.
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bacteria, ArfB (Supplementary Fig. 8a) is one of the three well-
known pathways of stalled-ribosome rescue, which also include
alternative rescue factor A with RF2 (ArfA•RF2; Supplementary
Fig. 8b) and trans-translation by SmpB•tmRNA (Supplementary
Fig. 8c)7,9. In eukaryotes, the Dom34/Pelota•Hbs1 complex
(Supplementary Fig. 8d), which structurally resembles the release
factor complex eRF1•eRF3, is the predominant rescue mechanism
for cytoplasmic ribosomes42–44, whereas ArfB-like ICT1 rescues
mitochondrial ribosomes12,13. Previous structural studies found
that these pathways involve proteins that recognize the vacant
mRNA tunnel. ArfA binds the mRNA tunnel to assist RF2 in
releasing the nascent peptide45–49. In trans-translation, small
protein B inserts into the tunnel and assists tmRNA to continue
translation of a stalled protein targeted for degradation50. Dom34
inserts a β-hairpin loop into the mRNA tunnel to release
peptidyl-tRNA from the ribosome51,52. Biochemical studies,
however, have demonstrated that these pathways can also
function on longer mRNAs. ArfA and SmpB function on +6
mRNAs, but their efficiencies are reduced on +9 substrates53,54.
Dom34 acts to rescue ribosomes stalled on poly-A sequences43,55,
echoing the roles of ArfB on rare-codon clusters. These data
suggest that trans-translation and ArfA-mediated release in
bacteria, as well as Dom34-mediated ribosome rescue in
eukaryotes can occur when mRNA spontaneously exits the
mRNA tunnel. While ArfB forms an mRNA-stabilizing homo-
dimer, the other rescue pathways are not known to involve dimer
formation. Isolated mitochondrial homolog ICT1 was reported to
dimerize in solution56, but it remains to be shown whether
ICT1 dimerizes to rescue stalled mitochondrial ribosomes. Cryo-
EM structure of Dom34 bound the 80S ribosome with a poly-A-
containing mRNA did not resolve mRNA beyond the P-site
codon52, suggesting that Dom34 can efficiently outcompete
mRNA that can stochastically leave the mRNA tunnel. Structural
studies of trans-translation, ArfA, and ICT1 on longer mRNAs
will help clarify how these rescue pathways function on mRNAs
of different lengths and sequences.
Methods
Preparation of 70S complexes with ArfB. Full-length E. coli ArfB (YaeJ) without
tags was subcloned into a pET24-b(+) plasmid from the ArfB-encoding ASKA
construct obtained from the National Bioresource Project (Japan). The protein was
overexpressed in E. coli BLR (DE3) (Novagen) cells. Upon achieving an optical
density of 0.8, the cells were induced with 1 mM IPTG and incubated at 16 °C
overnight in an orbital shaker. Cells were pelleted by spinning at 5000 rpm for
20 min and resuspended with buffer A (50 mM Tris pH 8.0, 50 mM ammonium
sulfate, 100 mM potassium chloride, and 5 mM 2-mercaptoethanol). Cells were
lysed, and the lysate was clarified by spinning at 18,000 rpm for 20 min. The
supernatant was loaded onto a Mono-S 5/50 GL column pre-equilibrated with
buffer A and eluted with buffer B (50 mM Tris pH 8.0, 50 mM ammonium sulfate,
1 M potassium chloride, and 5 mM 2-mercaptoethanol). Fractions containing ArfB
were pooled and re-applied to the Mono-S column. Fractions containing ArfB were
pooled and exchanged into buffer C (50 mM Tris pH 8.0, 300 mM potassium
chloride, 10% glycerol, and 5 mM 2-mercaptoethanol). The sample was applied to a
HiLoad 16/60 size exclusion column (prep grade) pre-equilibrated in buffer C.
Collected fractions containing pure ArfB (>95% estimated by PAGE electrophor-
esis) were concentrated and exchanged into storage buffer (20 mM Tris acetate pH
7.0, 10 mM ammonium acetate, 50 mM potassium acetate, and 10 mM magnesium
acetate) using centrifugal filters. E. coli tRNAfMet (Chemical Block) was aminoa-
cylated as described18. 70S ribosomes were prepared from E. coli (MRE600) as
described18. Ribosomes were stored in the ribosome storage buffer (20 mM Tris
hydrochloride pH 7.0, 100 mM ammonium chloride, 12.5 mM magnesium chlor-
ide, 0.5 mM ethylenediaminetetraacetic acid, and 6 mM 2-mercaptoethanol) at
−80 °C. Model mRNAs for this study (Supplementary Table 1), containing the
Shine-Dalgarno sequence and a spacer to position the AUG codon in the P site
(GGCAAGGAGGUAAAAAUG-overhang), were synthesized by IDT.
Biochemical activity of ArfB was measured using an in vitro assay that records
release of [35S]-formyl-methionine from the 70S ribosome bound with [35S]-fMet-
tRNAfMet in the P site, as described18. Pre-termination complex was prepared
using 100 nM E. coli 70S ribosomes (all concentrations are for the final reaction
mixture upon initiation of the release reaction), 4.95 µM mRNA, and 275 nM [35S]-
fMet-tRNAfMet ([35S]-methionine from Perkin Elmer). Concentrations were
determined using Nanodrop 2000c Spectrophotometer. The reaction was carried
out on ice with 10 µM ArfB, with 5-uL aliquots taken at 0, 6, 15, 30, 90, 300, 900,
1800, and 3600 s and quenched in 0.1 M HCl to represent reaction time points.
Formyl-methionine was extracted by ethyl acetate and radioactivity was measured
in a scintillation counter (Beckman Coulter, Inc) using a scintillation cocktail
(Econo-safe). All time-progress curve measurements were performed 3 times and
kobs were obtained by fitting single-exponential curves using GraphPad Prism8:
y= y0+ (Plateau-y0)*(1−e−kx).
For cryo-EM studies, two 70S•tRNAfMet•mRNA•ArfB complexes were
assembled as follows. 400 nM 70S ribosome (all concentrations are specified for the
final complex solution) was combined with 12 µM mRNA (mRNA+ 2: GGCAA
GGAGGUAAAAAUG-AA; mRNA+9: GGCAAGGAGGUAAAAAUG-UAAAAA
AAA) in buffer containing 20 mM Tris-acetate pH 7.0, 100 mM ammonium
acetate, and 20 mM magnesium acetate. After vortexing and incubation at 37 °C for
2 min, 600 nM tRNAfMet was added, vortexed, and incubated at 37 °C for 5 min.
Four micromolar ArfB was added to the 70S complex, vortexed, and incubated at
37 °C for 15 min. The sample (70S•tRNAfMet•mRNA•ArfB complex) was kept on
ice during grid preparation and plunging.
Cryo-EM and image processing. Holey-carbon grids (QUANTIFOIL R 2/1, Cu
200, 2 nm C grid, Quantifoil Micro Tools) coated with carbon were glow dis-
charged at 20 mA with negative polarity for 60 s in a PELCO easiGlow glow dis-
charge unit. 2.8 µl of the 70S•mRNA•tRNAfMet•ArfB complex was applied to the
grids. Grids were blotted at blotting force 8 for 6 s at 20 °C, 100% humidity and
plunged into liquid ethane using a Vitrobot MK4 (FEI). Grids were stored in liquid
nitrogen. Grid preparation for both data sets was identical.
+9 mRNA: A dataset of 197,913 particles was collected on a Titan Krios (FEI)
microscope (operating at 300 kV) equipped with a K2 Summit camera system
(Gatan), with 0.6 to 1.8 µm defocus. Multi-shot data collection was performed by
collecting 4 exposures from 4 holes using SerialEM57 with beam-image shift. Built-
in functions of SerialEM were used in performing coma-free alignment. The
“Coma vs. Image Shift” function was used to compensate for dynamic beam-tilt
occurring during each exposure. Multi-hole/multi-shot configuration was selected
from “Multiple Record Setup Dialog” to dynamically adjust the beam tilt and
mechanical drift was minimized by applying backlash-corrected compensation for
each stage adjustment. 1,777 movies were collected. Each exposure (35 frames per
movie) was acquired with continuous frame streaming, yielding a total dose of
49.6 e/Å. The nominal magnification was 130,000 and the calibrated super-
resolution pixel size was 0.521 Å. Movies with ice contamination or image
recording defects were discarded, yielding 1521 movies for data processing.
IMOD58 was used to align movies. Resulting images were binned to pixel size
1.042 Å (termed unbinned or 1× binned). cisTEM59 was used to determine defocus
values for each resulting frame average, for particle picking, for 2D classification to
remove poorly resolved and 50S particles, and for generating an ab initio model as
a template during alignment. The stack and particle parameter files were assembled
in cisTEM with the binnings of 1×, 2×, and 4× (box size of 360 for unbinned stack).
+2 mRNA: A dataset of 90,503 particles was collected in a similar manner to
the +9 mRNA dataset on the Talos-Arctica (FEI) microscope (operating 200 kV)
equipped with a K3 camera system (Gatan), with 0.5 to 1.5 µm defocus. Multishot
data collection was performed by collecting 4 exposures for 4 holes at a time,
following the same setup as described above. 1504 movies were collected. Each
exposure (27 frames per movie) was acquired with continuous frame streaming,
yielding a total dose of 30.5 e/ Å2. The nominal magnification was 45,000 and the
calibrated super-resolution pixel size was 0.435 Å. 1460 movies remained after
discarding those with obvious defects due from ice contamination. The frames for
each movie were processed as described above with the unbinned or 1× pixel size
measuring 0.87 Å. cisTEM was used to determine defocus values, pick particles, 2D
classify, and for generating an ab initio model to use for a template during
alignment. The stack and particle parameter files were assembled in cisTEM with
the binnings of 1×, 2×, and 4× (box size of 440 for unbinned stack).
+9 mRNA: FrealignX was used for particle alignment, refinement, and final
reconstruction steps, and Frealign v9.11 was used for classification steps60,61. The
4×-binned image stack (197,913 particles) was initially aligned to an ab initio
reference model—generated from 50% of the particles from this data set—using 3
cycles of mode 3 (global search) alignment, including data from 25 Å to 300 Å
resolution range. Using the 4×-binned stack, the particles were refined using mode
1 by gradually (1-5 Å per step) increasing the high-resolution limit from 25 to 9 Å
(3 cycles for each resolution limit). 3D density reconstruction was obtained using
60% of particles with highest scores. The map contained density for the P-tRNA,
mRNA, and ArfB. Conversion of parameter file from FrealignX to Frealign for
classification was performed by removing column twelve, which contains phase
shift information (not applicable as no phase plate was used) and adding an
absolute magnification value. Reverse conversion from Frealign to FrealignX for
refinement was performed automatically by FrealignX.
Data classification was performed as illustrated in Supplementary Fig. 3a, using
a spherical focused mask with a 40 Å radius, centered in the intersubunit space and
covering the A site and part of the P site (Supplementary Fig. 2d). The particle
stack was classified into 4 classes using the high-resolution limit of 12 Å. The
classification resulted in two classes of nonrotated ribosomes with ArfB bound
(Classes 1 and 2) and two classes of rotated ribosomes with ArfB (Classes 3 and 4).
All classes were reconstructed using the unbinned stack. Classes 3 and 4 were
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subclassified using the same 40 Å focused mask into 6 and 4 classes, respectively.
This subclassification revealed several ArfB-containing states (Supplementary
Table 3), which were subjected to final refinement with the high-resolution limit of
6 Å (Fig. 4b). Three maps were fitted with structural models to yield Structures +9-
IV (3.7 Å),+ 9-V (3.3 Å), and +9-VI (3.2 Å). Subclassification of Class 1 into 6
classes using the 40 Å focused mask produced multiple states, which were refined
and fit as described for Classes 3 and 4 (Supplementary Table 5). Two maps
containing ArfB yielded Structures +9-I (3.2 Å) and +9-II (3.5 Å). Class 2 was
subclassified using a 30 Å focused mask that covered the 50S A and P sites, as well
as the PTC (Supplementary Fig. 5d). This classification yielded Structure +9-III
(3.3 Å) after final refinement with a high-resolution limit of 6 Å.
+2 mRNA: Data processing of the +2 mRNA data set followed a similar
workflow as the +9 mRNA data set. In short, classification on the full stack using
the same 40 Å spherical focused mask for 100 cycles revealed two classes: monomer
ArfB bound to classical ribosomes and no ArfB bound to hybrid state ribosomes.
The ArfB containing class was subclassified again with the same mask which
produced three classes: no ArfB classical ribosomes, monomer ArfB bound classical
ribosomes (3.7 Å+ 2-II, high resolution limit of 6 Å), and collapsed, monomer
ArfB bound classical ribosomes. The collapsed, monomer class was further
classified using a 35 Å spherical focused mask around the peptidyl transferase
center and refined to produce 3.8 Å structure +2-III containing partially collapsed
ArfB and 3.7 Å structure +2-IV containing fully collapsed ArfB (high resolution
limit of 6 Å). The overall workflow for classification of the +2 mRNA data set can
be seen in Supplementary Fig. 2a, and the discussed classes are described in
Supplementary Table 2.
The resulting reconstructions varied from 3.3 Å (+9-III) to 3.8 Å (+2-III)
(Fourier Shell Correlation (FSC)= 0.143). Cryo-EM maps were B-factor sharpened
in bfactor.exe (part of Frealign distribution) using different B-factor values
(Supplementary Table 5) and then used for model building and structural
refinements. FSC curves were calculated by FrealignX for even and odd particle
half-sets (Supplementary Fig. 2b and Supplementary Fig. 3b).
Model building and refinement. Cryo-EM Structure I of 70S•fMet-tRNAfMet•
RF228 and the crystal structure of 70S•tRNAfMet•ArfB15 were used to create
initial models for structural refinements of the non-rotated ribosomes. Cryo-
EM Structure V of 70S•fMet-tRNAfMet28 was used to create initial models of the
rotated ribosomes. Chimera62 was used for fitting the 50S subunit, 30S
head with mRNA, 30S body, tRNA, and ArfB. N-terminal domain of ArfB-2 was
fitted into density as a rigid body, excluding the GGQ loop and the C-
terminal tail. Local model fitting was performed in PyMOL for areas that dif-
fered from the starting model, such as A-site mRNA and N-terminal residues of
ArfB-263.
The structural models were refined by real-space simulated-annealing
refinement using atomic electron scattering factors in RSRef and Phenix, as
described32,64–66. During refinement in RSRef, secondary-structure restraints,
comprising hydrogen bonding restraints for ribosomal proteins and ArfB, and
base-pairing restraints for RNA molecules, were employed as described67.
Refinement parameters, such as the relative weighting of stereochemical restraints
and experimental energy term, were optimized to produce the models with good
stereochemistry that closely agree with the corresponding maps. The structures
were next refined using phenix.real_space_refine68, followed by a round of
refinement in RSRef with harmonic restraints applied to all proteins to preserve the
backbone geometry. In the final step, structure B-factors were refined in Phenix
against the respective maps. The resulting structural models have good
stereochemical parameters, evidenced by low deviation from ideal bond lengths
and angles, high correlation coefficients, and low real space R factors
(Supplementary Table 5). Structure quality was validated using MolProbity69.
Figures were prepared in Chimera, Graphpad Prism8, and PyMOL.
Description of structures. Cryo-EM maps for all structures were deposited in
EMDB. PDB structures were deposited in RCSB, except for Structures +2-I, +2-V,
+9-I, +9-V, and +9-VI, which are similar to published structures, as
described below.
Structure +2-I is a non-rotated 70S•tRNAfMet without ArfB. The +2 mRNA
assumes an identical conformation across all five +2 structures, Structure +2-I can
be recreated in PyMOL by removing ArfB from +2-II.
Structure +2-V is a rotated 70S•tRNAfMet with P/E tRNA and helix 69 (H69)
disengaged from the decoding center, similar to the reported Structure V (without
RF2) in PDB:6OGI70, except the different mRNA identity and conformation of the
decoding center (see description for +2-I).
Structure +9-I is a non-rotated 70S•tRNAfMet with the C-terminus of ArfB
(residues 107–133) resolved in the mRNA tunnel. No density for the N domain of
ArfB or mRNA residues beyond the P site were observed. +9-I is therefore similar
to +9-III without mRNA after the P site, ArfB-2, and ArfB-1 residues 1-106.
Structure +9-V is a rotated 70S•tRNAfMet with P/E tRNA, mRNA resolved
through the P site, and ArfB N and C domains (residues 1-20, 36-100, and 111-133).
Structure +9-VI is similar to +2-V, except that mRNA resides inside the
mRNA tunnel as in PDB PDB:4V6G (Supplementary Fig. 7c71).
Data availability
The data that support this work is available from the corresponding author upon
reasonable request. The models and cryo-EM maps described in this study are available
from RCSB PDB and EMDB with the following accession codes:+2-I (EMD-22465), +2-
II (EMD-22459, PDB 7JSS), +2-III (EMD-22461, PDB 7JSW), +2-IV (EMD-22464, PDB
7JSZ), +2-V (EMD-22467). +9-I (EMD-22468), +9-II (EMD-22469, PDB 7JT2), +9-III
(EMD-22466, PDB 7JT1), +9-IV (EMD-22472, PDB 7JT3), +9-V (EMD-22471), and
+9-VI (EMD-22470). Source data are provided with this paper.
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